Evolver™ can also be utilized to analyze biological data generated by the products or sensors of 3rd party companies to create additional high-value diagnostic, prognostic or therapeutic selection tests and services.
Consequently, EGI is selectively in-licensing and acquiring devices (such as CardioDefender and AngioDefender) which are commercially compelling in their own right, will benefit from the application of the Evolver™ platform and result in added value tests and services.
Note: The IBM logo and Blue Gene/P product name and trademarks are the property of IBM.